매출 흑자인데 영업CF 적자 (OCF/매출 -13%). 통계적 정황 신호이며 회계부정 단정이 아닙니다.
Novavax
NVAX-US · NasdaqNovavax — pricey right now, or cheap? And what signals are flashing today?
The grade and valuation bands are below — free to read.
Why these signals fired — only backtest-proven edge, told honestly
New high + volume — the real recordrecord · not a prediction
Not this one stock, but every new-high-plus-volume pick we actually published (US market). When this stock flashes the signal, it is treated by the same rule.(as of 2026-08-25)
Beat the market on 40.6% of picks (each pick vs its own day’s market average).
Entry is the latest close at publish time; next-day is the following close. “Market” is the equal-weighted average of every stock in the same market that day; delisted names are excluded from both. Fees, taxes and slippage are not included. An observed record over a short window, not a pre-registered backtest. Not investment advice.
Trade plan
Decide the exit before you enter. Set what you are willing to lose first, and the share count follows — so you know the worst case before you buy.
Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.
This is a calculator, not advice, and it does not promise any outcome. You choose the stop and target — the button values (ATR, recent low/high) are observations from past prices. Actual fills depend on the order book and liquidity.
Valuation Grades
Relative to 752 건강관리 peers · not investment advice
Valuation in its own history
PER — · PBR — — own history (2000-01~) percentiles 49/100 · —/100
Higher indicates lower valuation relative to its history (based on earnings and book yields).
Earnings percentiles can fluctuate for cyclical companies (including loss periods), so the book basis is shown alongside. Companies with large share buybacks can have structurally high PBR. Factual information, not investment advice.
Financial safety
Reference indicatorAs of 2024- Altman Z''
- -11.94
- Beneish M-Score
- -3.66
- Sloan accrual
- -6.42%
No statistical flag
부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.
Factual information, not investment advice.
Earnings quality · Piotroski F-Score
Piotroski measures year-over-year financial improvement, not absolute quality.
Profitability
- Positive ROANot passed
- Positive OCFNot passed
- Improving ΔROAPass
- Accruals (OCF > net income)Pass
Leverage & liquidity
- Lower debtNot passed
- Higher current ratioPass
- No new sharesNot passed
Efficiency
- Higher gross marginPass
- Higher asset turnoverNot passed
Calculation note: F7(신주)은 equity/asset 유지로 근사
Already-stable companies may score lower when year-over-year improvement is limited.
Factual information, not investment advice.
Forensic signals
Anomaly and structural signals observed in the financial statements.
자본잠식 — 자본총계가 마이너스입니다. 부실 위험을 나타내는 사실 지표입니다.
Factual information, not investment advice.
Industry structure
USAs of 2026-08-25건강관리
This stock is in 건강관리: revenue rank 149 of 547, share 0%.
Who dominates this industry?
- 1CVS Health14.1%
- 2McKesson13.6%
- 3Cigna9.4%
- 4Cardinal Health8.4%
- 5Centene6.2%
- 6Novavax0%
Concentration
DistributedCR3 37.1%HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.
Polarization
Winner-take-all deepeningConsistentPolarization measures industry gaps and structure, not valuation, forecast, or investment advice.
Margin lens
- IQR%p
- 159.97
- Direction
- 축소
- Level
- 넓음
- Years
- 21
Value lens
- P90/P10
- 23.8
- Median P/B
- 3.04
- Level
- 넓음
- n
- 465
Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)
Factual information, not investment advice.
Risk sensitivity — adverse assumptions
Metric changes under stated assumptions; not a forecast or investment advice.
Base metrics
- Operating margin
- -36.5%
- Interest coverage
- -12.4x
- Return on equity (ROE)
- —
Operating margin −5pp
Operating lossRevenue −15%
Interest coverage riskInterest rate +2pp
Interest coverage riskInterest coverage limit
Already below the limit by 39.4ppInterest coverage limit at an operating margin of 2.9%
Interest expense coverage threshold
Financials at a glance
Novavax's latest results and balance sheet. The bars track the last three periods.
Who held it · filings
Filed recordA historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.
Curated gurus reporting this holding
A curated subset of well-known investors — not the full institutional ownership.
- Coatue Management3,836,986주2026-06-30 · 증감 0주
Other stocks held by the same investors
A filing-based shared-holder record, not investment advice.
- Arbor Realty Trust REITUSABR-US →
Shared holders: Coatue Management
- ArganUSAGX-US →
Shared holders: Coatue Management
- Applied MaterialUSAMAT-US →
Shared holders: Coatue Management
- AMC Entertainment Holdings Class AUSAMC-US →
Shared holders: Coatue Management
- Advanced Micro DevicesUSAMD-US →
Shared holders: Coatue Management
- Amazon ComUSAMZN-US →
Shared holders: Coatue Management
- AppLovin Class AUSAPP-US →
Shared holders: Coatue Management
- ASML Holding NV ADRUSASML-US →
Shared holders: Coatue Management
Connections
AI-extracted related companies · for reference
Recent filings
Filings for overseas stocks are on the way. For now we cover Korean stocks only.
Like these rules? Run them automatically.
Quantus turns rules like these into backtests and automated trading — same team, free to start.
Quantus Signal · live data · not investment advice · Privacy Policy